What are the typical presentation and treatment options for eczema (atopic dermatitis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Atopic Dermatitis: Presentation and Treatment

Atopic dermatitis is characterized by itchy skin with age-dependent distribution patterns, affecting 5-15% of children and 2-10% of adults, and should be treated with liberal emollient application as baseline therapy, with topical corticosteroids as first-line treatment for flares. 1

Typical Presentation

Diagnostic Features

  • Itchy skin condition plus three or more of the following:
    • History of itchiness in skin creases
    • History of asthma/hay fever or atopic disease in first-degree relatives
    • General dry skin
    • Visible flexural eczema
    • Onset in the first two years of life 1

Age-Dependent Distribution

  • Infants: Lesions primarily on cheeks and scalp (diaper area rarely affected)
  • Young children: Involvement of extremities, cheeks, forehead, and neck
  • Older children and adults: Flexural areas (antecubital and popliteal fossae), head, and neck 1, 2

Lesion Characteristics

  • Acute: Erythematous papules with serous exudates
  • Subacute: Erythematous scaling papules and plaques
  • Chronic: Lichenified skin with accentuated markings and hyperpigmentation 2

Treatment Approach

First-Line Management

  1. Emollients and Skin Care

    • Apply liberally and frequently, especially after bathing
    • Use soap-free cleansers for bathing
    • Consider dispersible creams as soap substitutes 1
  2. Trigger Avoidance

    • Identify and eliminate triggering substances
    • Avoid irritant clothing and extremes of temperature
    • Keep nails short to minimize damage from scratching 1
  3. Topical Anti-inflammatory Therapy

    • Topical Corticosteroids (TCS):

      • Low-potency: For face, short-term use
      • Medium-potency: Once daily for 2-4 weeks for mild to moderate cases
      • High-potency: Short periods on thickened areas in severe cases 1
    • Topical Calcineurin Inhibitors (TCI) like pimecrolimus:

      • For patients 2 years and older
      • Not for continuous long-term use due to potential safety concerns
      • Should not be used in immunocompromised patients 3
      • Can be used in conjunction with TCS as first-line treatment 4

Proactive Maintenance Therapy

  • Apply TCS or TCI twice weekly to previously affected areas to prevent relapse
  • Continue regular emollient use on all skin 1, 5

Secondary Infection Management

  • Obtain bacterial cultures if secondary infection is suspected
  • Administer appropriate antibiotics based on culture results
  • For eczema herpeticum: Prompt systemic antiviral therapy (IV acyclovir for severe cases) 1

Advanced Therapies for Moderate to Severe Cases

  • Phototherapy: Safe and effective when first-line treatments are inadequate 4
  • Systemic options:
    • Consider if more than 20% of body surface area is affected
    • Options include immunosuppressants or biologics 1
    • Oral antihistamines may help with severe itching but do not directly treat the eczema 1

Common Pitfalls to Avoid

  • Using potent topical corticosteroids on the face for prolonged periods
  • Neglecting to identify and avoid triggers
  • Using topical antihistamines (ineffective and potentially sensitizing)
  • Long-term use of topical antibiotics (promotes resistance)
  • Neglecting patient education about proper application of treatments 1
  • Using pimecrolimus (Elidel) in children under 2 years of age 3
  • Continuous long-term use of calcineurin inhibitors without breaks 3

Special Considerations

  • Deterioration in previously stable eczema may indicate secondary infection or contact dermatitis
  • Dietary restrictions have little benefit in adults but may be considered in selected infants under professional supervision
  • The chronic nature of atopic dermatitis requires long-term management strategies 1, 6
  • Atopic dermatitis increases risk of food allergy, asthma, allergic rhinitis, and other immune-mediated inflammatory diseases 6

References

Guideline

Atopic Dermatitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Chapter 20: Atopic dermatitis.

Allergy and asthma proceedings, 2012

Research

Atopic Dermatitis: Diagnosis and Treatment.

American family physician, 2020

Research

Atopic dermatitis.

Lancet (London, England), 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.